Elicio Therapeutics Inc Quick Ratio (ELTX) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Elicio Therapeutics Inc   (NASDAQ: ELTX)

Elicio Therapeutics Inc 's Quick Ratio

ELTX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Elicio Therapeutics Inc 's Cash & cash equivalent grew by 31.6 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Elicio Therapeutics Inc 's Quick Ratio to 3.11, above Elicio Therapeutics Inc average Quick Ratio.

Within Major Pharmaceutical Preparations industry 256 other companies have achieved higher Quick Ratio than Elicio Therapeutics Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1040 to 1233.

Explain Quick Ratio?
How much Cash & cash equivalents ELTX´s has?
What are ELTX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELTX Quick Ratio (Sep 30 2026)
Q3		 (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3
Y / Y Current Liabilities Change 52.42 % -7.27 % -36.66 % -29.62 % -27.77 %
Y / Y Cash & cash equivalent Change 49.92 % 6.3 % -18.54 % 5.36 % -20.78 %
Quick Ratio MRQ 3.11 2.55 2.07 2.29 3.16
ELTX's Total Ranking # 1233 # 1040 # 687 # 616 #
Seq. Current Liabilities Change 7.91 % 27.29 % -10.86 % 24.48 % -34.34 %
Seq. Cash & cash equivalent Change 31.6 % 57.08 % -19.47 % -9.94 % -6.69 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 257
Healthcare Sector # 442
Overall Market # 1233


Quick Ratio Statistics
High Average Low
7.86 2.88 0.08
(Dec 31 2021)   (Jun 30 2022)




Financial Statements
Elicio Therapeutics Inc 's Current Liabilities $ 10 Millions Visit ELTX's Balance sheet
Elicio Therapeutics Inc 's Cash & cash equivalent $ 31 Millions Visit ELTX's Balance sheet
Source of ELTX's Sales Visit ELTX's Sales by Geography


Cumulative Elicio Therapeutics Inc 's Quick Ratio

ELTX's Quick Ratio for the trailling 12 Months

ELTX Quick Ratio

 (Sep 30 2026)
12 Months		 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -12.45 % -25.84 % -19.64 % 5.52 % 7.98 %
Y / Y Cash & cash equivalent TTM Growth 11.72 % -7.7 % 16.51 % 35.14 % 45.18 %
Quick Ratio TTM 2.55 2.5 2.4 2.21 2
Total Ranking TTM # 3769 # 2677 # 2865 # 2442 #
Seq. Current Liabilities TTM Growth 11 % -2.27 % -11.63 % -8.67 % -5.98 %
Seq. Cash & cash equivalent TTM Growth 13.26 % 1.83 % -4.27 % 1.2 % -6.43 %

Quick ratio ranking by company, industry and sector >> Back to ELTX Financial Strength Comparisons >> Go to Compare ELTX Quick Ratio to its Competitors

On the trailing twelve months basis ELTX Cash & cash equivalent soared by 49.92 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Elicio Therapeutics Inc 's Quick Ratio to 2.55, Quick Ratio remained below ELTX average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 430 other companies have achieved higher Quick Ratio than Elicio Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2677 to 3769.

Explain Quick Ratio?
How much Cash & cash equivalents ELTX´s has?
What are ELTX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 431
Healthcare Sector # 876
Within the Market # 3769


trailing twelve months Quick Ratio Statistics
High Average Low
6.58 2.97 0.69
(Dec 31 2021)   (Mar 31 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Arvinas Inc   7.98 $ 558.400  Millions$ 70.000  Millions
Wave Life Sciences Ltd   7.87 $ 431.012  Millions$ 54.760  Millions
Viking Therapeutics Inc   7.17 $ 959.813  Millions$ 133.897  Millions
Lb Pharmaceuticals Inc  7.03 $ 215.075  Millions$ 30.573  Millions
Nuvation Bio Inc   6.73 $ 663.370  Millions$ 98.559  Millions
Arcturus Therapeutics Holdings Inc   6.52 $ 184.817  Millions$ 28.345  Millions
Moonlake Immunotherapeutics  6.50 $ 379.704  Millions$ 58.430  Millions
Camp4 Therapeutics Corporation  6.27 $ 124.522  Millions$ 19.865  Millions
Cartesian Therapeutics Inc   6.12 $ 122.975  Millions$ 20.088  Millions
Summit Therapeutics Inc   5.71 $ 629.899  Millions$ 110.226  Millions
Nurix Therapeutics Inc   5.51 $ 720.458  Millions$ 130.742  Millions
United Therapeutics Corporation  5.51 $ 3,439.800  Millions$ 624.300  Millions
Immuneering Corporation  5.45 $ 58.776  Millions$ 10.791  Millions
Aquestive Therapeutics Inc   5.22 $ 90.349  Millions$ 17.299  Millions
Shattuck Labs Inc   4.84 $ 61.758  Millions$ 12.758  Millions
Entrada Therapeutics Inc   4.34 $ 112.302  Millions$ 25.863  Millions
Gyre Therapeutics Inc   4.34 $ 86.190  Millions$ 19.874  Millions
Revelation Biosciences Inc   3.92 $ 9.122  Millions$ 2.328  Millions
Lyell Immunopharma Inc   3.83 $ 177.106  Millions$ 46.271  Millions
Rapport Therapeutics Inc   3.68 $ 74.754  Millions$ 20.302  Millions
Seaport Therapeutics Inc   3.60 $ 61.552  Millions$ 17.106  Millions
Cytokinetics Incorporated  3.20 $ 1,130.021  Millions$ 353.419  Millions
Elicio Therapeutics Inc   3.11 $ 30.900  Millions$ 9.930  Millions
Harmony Biosciences Holdings inc   3.02 $ 771.138  Millions$ 254.981  Millions
Phio Pharmaceuticals Corp  2.96 $ 10.609  Millions$ 3.583  Millions
Zevra Therapeutics Inc   2.95 $ 122.148  Millions$ 41.369  Millions
Ptc Therapeutics inc   2.74 $ 2,127.918  Millions$ 776.076  Millions
Beone Medicines Ltd   2.67 $ 5,955.905  Millions$ 2,233.923  Millions
Biohaven Ltd   2.57 $ 161.125  Millions$ 62.767  Millions
Opko Health Inc   2.37 $ 384.036  Millions$ 162.356  Millions

Date modified: 2026-11-06T13:00:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.